New CAR-T cell therapy targets aggressive brain tumors

Researchers at Nature News found that an engineered CAR-T cell therapy, targeting the GPNMB protein, effectively shrank glioblastoma tumors in preclinical models. This dual-targeting approach could offer a new way to fight one of the most aggressive brain cancers. The study was led by Dr. John Smith.